Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential determination of effective dose of ciprofol + remifentanil for adult general anesthesia without muscle relaxant (laryngeal mask)
ChiCTR2500104632Phase 4Recruiting
- Sponsor
- The Affiliated Shunde Hospital of Jinan University
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and remifentanil (2 arms), sponsored by The Affiliated Shunde Hospital of Jinan University. Primary endpoints: ED50 and ED95 of remifentanil and ED50 and ED95 of ciprofol. Started Jun 2025; status: recruiting.
02
Drugs
ciprofolremifentanil
Beyond the preview
Go deeper on ChiCTR2500104632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104632.